X

Vous n'êtes pas connecté

Maroc Maroc - ONCOLOGYNEWS.COM.AU - A La Une - 15/11/2024 07:02

Bacterial vaccine shows promise as cancer immunotherapy

Columbia researchers have engineered probiotic bacteria that educate the immune system to destroy cancer cells, opening the door for a new class of cancer vaccines that take advantage of bacteria’s natural tumour-targeting properties. These microbial cancer vaccines can be personalised to attack each individual’s primary tumour and metastases, and may even prevent future recurrences. In [...]

Articles similaires

Engineered gut bacteria improves survival outcomes in colorectal cancer tumours

oncologynews.com.au - 03:27

In a new study that combines synthetic biology with cancer immunotherapy, researchers from the Yong Loo Lin School of Medicine, National University of...

Sorry! Image not available at this time

Patient-Derived Dendritic Cell Immunotherapy Targets Difficult-to-Treat Cancers

wn.com - 25/Sep 14:24

Treating the brain cancer glioblastoma (GBM) demands more than conventional strategies due to a mix of factors including the cancer’s genetic...

Sorry! Image not available at this time

Patient-Derived Dendritic Cell Immunotherapy Targets Difficult-to-Treat Cancers

wn.com - 25/Sep 14:24

Treating the brain cancer glioblastoma (GBM) demands more than conventional strategies due to a mix of factors including the cancer’s genetic...

New molecule offers a more targeted and potent immunotherapy

news.medical.net - 18/Sep 04:47

A newly developed molecule brings together two powerful immunotherapy strategies in one treatment. Researchers at the University of Basel and...

Sorry! Image not available at this time

Peptide Cancer Vaccine Market Opportunity, Technology Platforms & Clinical Trials Insight Report to 2030: U.S. Leads in Peptide Vaccine Development with Over 20 Active Projects - ResearchAndMarkets.com

wn.com - 15/Sep 17:35

DUBLIN--(BUSINESS WIRE)--The "Peptide Cancer Vaccine Market Opportunity, Technology Platforms & Clinical Trials Insight 2030" report has been...

Genetic modification enhances "living drugs" for blood cancers

news.medical.net - 25/Sep 04:18

CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping...

CELLFIE: Genetic boosters power up CAR-T cells

oncologynews.com.au - 25/Sep 23:48

CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in modern medicine....

Lung cancer cells in the brain form electrical connections with neurons that spur tumour growth

oncologynews.com.au - 22/Sep 14:54

Small cell lung cancer cells that metastasise to the brain cosy up to neurons and form working electrical connections, called synapses, according to...

UCLA team develops engineered antibodies to fight cytomegalovirus infection

news.medical.net - 14/Sep 02:21

A UCLA research team has found a new way to prompt the immune system to kill cells infected with cytomegalovirus (CMV), a life-threatening infection...

Research breakthrough offers hope for new colorectal cancer treatments

oncologynews.com.au - 04:50

Fusobacterium nucleatum (F.nucleatum) is an anaerobic bacterium notably enriched in the gut microbiota of colorectal cancer (CRC) patients and may...